Evaluation of antimicrobial effectiveness of ophthalmic drops according to the pharmacopeial tests criteria

Daru

Volumn 17, Issue 1, 2009, Pages 13-18

  Samadi, N ^a   Tarighi, P ^b   Fazeli, M R ^a   Mehrgan, H ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial effectiveness test; Challenge test; Eye drop; Ophthalmic drop; Preservative

Indexed keywords

ARTIFICIAL TEAR; ATROPINE; BETAMETHASONE; EYE DROPS; HOMATROPINE; PHENYLEPHRINE; PILOCARPINE; PRESERVATIVE; TETRACAINE; TROPICAMIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; DRUG CONTAMINATION; DRUG DETERMINATION; MICROBIAL SENSITIVITY TEST; NONHUMAN; PLATE COUNT; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 62649086606     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Flores M, Morillo M, Crespo ML. Deterioration of raw materials and cosmetic products by preservative resistant microorganisms. Int Biodeter Biodeg 1997; 40: 157-160.
2. Ford J, Brown M, Hunt P. Serratia keratitis following use by hospital out-patients. J Clin Hosp Pharm 1985; 10: 203-209.
3. Schein OD, Wasson PJ, Boruchoff A, Kenyon KR. Microbial keratitis associated with contaminated ocular medications. Am J Ophthalmol 1988; 105: 361-365.
4. Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR. Microbial contamination of in-use ocular medications. Arch Ophthalmol 1992; 110: 82-85.
5. Furrer P, Mayer JM, Gurny R. Ocular tolerance of preservatives and alternatives. Eur J Pharm Biopharm 2002; 53: 263-280.
6. Wallhausser KH. Preservation and sterility of ophthalmic preparations and devices. In: Deasy PB, Timoney RF, ed. Quality Control of Medicines. Amsterdam: Elsevier; 1979. p. 199-213.
7. Fazeli MR, Samadi N, Fattahi M. Bioburden of pharmacy prepared eucerin-urea ointments. IJPR 2004; 3: 47-50.
8. Nostro A, Cannatelli MA, Morelli I, Musolino AD, Scuderi F, Pizzimenti F. Efficiency of Calamintha officinalis essential oil as preservative in two topical product types. J Appl Microb 2004; 97: 395-401.
9. Sutton S, Porter D. Development of the antimicrobial effectiveness test as USP chapter <51>. PDA J Pharm Sci Technol 2002; 56: 300-311.
10. Efficacy of antimicrobial preservation. British Pharmacopoeia. London: The Stationery Office; 2005. Appendix XVI C A367-A369.
11. Antimicrobial effectiveness testing. United States Pharmacopeia (USP 29). Rockville, MD: The United States Pharmacopeial Convention INC; 2006. p. 2499-2500.
12. Davison AL, Hooper WL, Spooner DL, Farwell JA, Baird R. The validity of the criteria of pharmacopoeial preservative efficacy tests-a pilot study. Pharm J 1991; 4: 555-557.
13. Fazeli MR, Behesht Nejad H, Mehrgan H, Elahian L. Microbial contamination of preserved ophthalmic drops in out-patient departments: possibility of an extended period of use. Daru 2004; 12: 31-36.
14. Validation of microbial recovery from pharmacopeial articles. United States Pharmacopeia (USP 29). Rockville, MD: The United States Pharmacopeial Convention INC; 2006. p. 3053-3055.
15. Mehrgan H, Elmi F, Fazeli MR, Shahverdi AR, Samadi N. Evaluation of neutralizing efficacy and possible microbial cell toxicity of a universal neutralizer proposed by the CTPA. IJPR 2006; 3: 173-178.
16. Coad CT, Ostao MS, Wilhelmus KR. Bacterial contamination of eye-drop dispensers. Am J Ophthalmol 1984; 98: 548-551.
17. Livingstone DJ, Hanlon GW, Dyke S. Evaluation of an extended period of use for preserved eye drops in hospital practice. Br J Ophthalmol 1998; 82: 473-475.
18. Rauz S, Moate BJR, Jacks AS, Cumberland N, Govan JAA. 'In use' expiry date for eyedrops. Br J Ophthalmol 1996; 80: 270.